Interleukin -18 (IL-18) and tumor necrosis factor (TNF) in sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 434s Year: 2002
Does tumour necrosis factor-alpha (TNF-alpha) induced by lipopolysaccharide have a positive feedback effect on the up-regulation of interleukin-8 (IL-8) messenger RNA by monocytes from COPD patients? Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013
Implication of leptin, tumor necrosis factor-alpha, interleukin-1 and interleukin-6 in the pathogenesis of wasting in tuberculosis Source: Annual Congress 2006 - Immunology of tuberculosis and diagnosis of tuberculosis infection Year: 2006
Evaluation levels of pro-inflammatory cytokines tumour necrosis factor (TNF)-alpha and interleukin (IL) 1-beta in small cell lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 233s Year: 2001
Prognostic meaning of interleukin-8 (IL-8) and interleukin-10 (IL-10) during the development of postoperative pneumonias Source: Eur Respir J 2005; 26: Suppl. 49, 633s Year: 2005
Levels of interleukins IL-4, IL-6, IL-8 and TNFa in sera of patients with tuberculosis before and during treatment Source: Eur Respir J 2002; 20: Suppl. 38, 556s Year: 2002
Use of interleukin-1beta (IL-1beta) and interleukin-1 receptor antagonist (IL-1Ra) contents in alveolar macrophages for estimation of inflammation activity in patients with different levels of asthma control Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013
The levels of tumour necrosis factor-alpha and interleukin-1 in newly diagnosed and multi drug resistant tuberculosis Source: Annual Congress 2004 - Clinical and diagnostic features of tuberculosis Year: 2004
Cytokines in asthma Source: Eur Respir J 2001; 18: 24S-33S Year: 2001
The levels of osteoprotegerin (OPG), interleukin 18 (IL-18) and soluble interleukin 2 receptor (sIL-2R) in serum during chemotherapy of lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 318s Year: 2004
Re-activation of bovine tuberculosis in a patient treated with infliximab Source: Eur Respir J 2008; 32: 229-231 Year: 2008
Relationship between interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-alpha), C-reaktive protein (CRP), albumin (ALB) and alkaline phosphatase (ALP) in bronchoalveolar lavage fluid (BALF) of patients with interstitial lung disease Source: Eur Respir J 2006; 28: Suppl. 50, 98s Year: 2006
Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis Source: Eur Respir J 2008; 32: 1607-1615 Year: 2008
Interferon (-alpha, -beta, and -omega) receptor 2 (IFNAR2) is a prognostic biomarker for lung cancer Source: Annual Congress 2011 - Innovative diagnostic methods for lung cancer Year: 2011
Pulmonary tuberculosis (PT) in patients taking the TNF-a inhibitor inflixinab (INF) Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts Year: 2011
Pro- and anti-inflammatory cytokines TNF-alpha, IFN-gamma, IL-10 and TGF-beta1 levels in blood serum as markers of plasmaferesis success and inflammation activity in lung sarcoidosis (LS) Source: Eur Respir J 2006; 28: Suppl. 50, 676s Year: 2006
A screening for latent tuberculosis infection among candidates to anti-tumor necrosis factor-alpha agents using a whole blood interferon-gamma test Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease Year: 2008
Mould exposure at home relates to inflammatory markers in blood Source: Eur Respir J 2003; 21: 317-322 Year: 2003
Decreased levels of CXC angiogenic chemokines (IL-8, ENA-78 and GRO-α) in BALF after interferon gamma-1b treatment in IPF patients Source: Eur Respir J 2005; 26: Suppl. 49, 267s Year: 2005
Lung expression of interleukin-13 (IL-13) and interferon gamma (IFNg) in emphysema in human Source: Eur Respir J 2002; 20: Suppl. 38, 584s Year: 2002